Page last updated: 2024-12-05

pinacol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pinacol : A glycol that is ethylene glycol in which all four methylene hydrogens have been replaced by methyl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6425
CHEMBL ID3289669
CHEBI ID131185
SCHEMBL ID8968

Synonyms (51)

Synonym
AC-4658
wln: qx1&1&xq1&1
pinacone
tetramethylethylene glycol
76-09-5
nsc25943
pinacol
nsc-25943
nsc 25943
einecs 200-933-5
ai3-02251
brn 1340501
1,1,2,2-tetramethylethylene glycol
2,3-dimethylbutane-2,3-diol
2,3-dimethyl-2,3-butanediol
2,3-butanediol, 2,3-dimethyl-
inchi=1/c6h14o2/c1-5(2,7)6(3,4)8/h7-8h,1-4h
pinacol, 98%
D0691
CHEBI:131185
2,3-dihydroxy-2,3-dimethylbutane
2,3-dimethyl-2,3-dihydroxybutane
A838608
AKOS007930158
2,3-dimethyl-butane-2,3-diol
STL256832
4-01-00-02575 (beilstein handbook reference)
unii-527qe7i5co
527qe7i5co ,
FT-0609691
pinacol [mi]
BP-21164
CHEMBL3289669
SCHEMBL8968
2,3-dimethyl-2,3-butandiol
meso-2,3-dimethyl-2,3-butanediol
DTXSID3058793
W-104376
mfcd00004462
CS-0015356
F0001-1921
pinacol, >=98%
SY001866
Q421634
AS-12465
AMY41207
D71083
pinacol pinacone 2,3-dimethyl-2,3-butanediol
EN300-39352
2,3-dimethyl-2,3-butanediol, tetramethylethylene glycol
Z382716052
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
glycolA diol in which the two hydroxy groups are on different carbon atoms, usually but not necessarily adjacent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1152455Drug level in deuterated phosphate buffer treated with 40 mM N,N-Bis(2-chloroethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline after 24 hrs by 1H-NMR analysis2014Journal of medicinal chemistry, Jun-12, Volume: 57, Issue:11
Reactive oxygen species (ROS) inducible DNA cross-linking agents and their effect on cancer cells and normal lymphocytes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (47.06)24.3611
2020's9 (52.94)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 60.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index60.39 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index95.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (60.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]